Table 3.
Mean glutamine and glutamate concentration (mmol/L) over time
| ROI | Group | Visit 1 | Visit 3 | Visit 5 | Visit 7 |
|---|---|---|---|---|---|
| rACC | Pregabalin | 5.93 (± 2.75) | 5.52 (± 3.02) | 8.47 (± 3.87) | 6.32 (± 2.83) |
| Placebo | 6.58 (± 3.26) | 5.50 (± 2.74) | 5.96 (± 1.91) | 5.83 (± 2.54) | |
| DLPFC | Pregabalin | 6.36 (± 1.07) | 5.63 (± 1.78) | 6.55 (± 0.84) | 6.28 (± 1.98) |
| Placebo | 5.98 (± 1.88) | 6.29 (± 1.89) | 5.29 (± 1.77) | 5.49 (± 1.39) | |
| Thalamus left | Pregabalin | 6.34 (± 1.66) | 7.17 (± 2.09) | 5.84 (± 1.78) | 7.04 (± 3.87) |
| Placebo | 5.15 (± 1.67) | 5.69 (± 1.68) | 5.05 (± 2.17) | 6.31 (± 1.43) | |
| Right thalamus | Pregabalin | 5.92 (± 1.99) | 5.78 (± 1.29) | 5.42 (± 1.19) | 6.61 (± 1.35) |
| Placebo | 6.68 (± 1.59) | 5.29 (± 0.93) | 6.08 (± 2.26) | 7.83 (± 3.01) |
Data are presented as the mean ± SD